Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a new history entry on 2026-03-24 for Study Status. The 2026-03-23 entry shows 56 changes, and the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded a new Revision: v3.5.0 entry and removed Revision: v3.4.3 from the history.SummaryDifference0.1%

- Check43 days agoChange DetectedThe latest revision (v3.4.3, 2026-02-27) adds Contacts/Locations and Study Status; the prior revision (v3.4.2, 2026-01-20) was deleted.SummaryDifference0.3%

- Check65 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2 on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded a new revision entry v3.4.1 and removed v3.4.0 from the record history. This update keeps the historical record current and accurate.SummaryDifference0.1%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.